Client News

American Rebel (NASDAQ: AREB) Reaches Distribution Agreement with Best Brands of Tennessee for American Rebel Beer

Nashville, TN, April 22, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel, and American Rebel Beer (www.americanrebelbeer.com), is proud to announce a distribution agreement with Best Brands Inc (www.bestbrandsinc.com) for the state of […]

Tiziana Life Sciences (Nasdaq: TLSA) Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access Program

70% of Patients in the Expanded Access Program (EAP) Have Seen Measurable Clinical Improvement in Their Fatigue After Six Months of Follow-up All Patients Have Either Stabilized or Improved on Nasal Foralumab Treatment and No Patients Declined in Key Clinical Measures NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) […]

Tiziana Life Sciences (Nasdaq: TLSA) Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®

– Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) – – Data presented in a platform session at the Annual Meeting of the American Academy of Neurology in Denver, Colorado – NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: […]

NKGen Biotech (Nasdaq: NKGN) Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

SANTA ANA, Calif., April 18, 2024 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer (“NK”) cell therapeutics, today announced that Paul Y. Song, MD, Chairman and Chief Executive Officer of NKGen Biotech, will […]

Longeveron (NASDAQ: LGVN) Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering

MIAMI, April 18, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, today announced the closing of its previously announced exercise of certain existing warrants to purchase […]

American Rebel (NASDAQ: AREB) Reaches Distribution Agreement with Standard Beverage Corporation of Kansas for American Rebel Beer

  American Rebel Holdings Inc Nashville, TN, April 18, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel, and American Rebel Beer (www.americanrebelbeer.com), is proud to announce a distribution agreement with Standard Beverage Corporation […]

Laser Photonics (NASDAQ: LASE) To Attend Government Fleet Expo & Conference 2024 With Its Selection of Laser Solutions

ORLANDO, Fla., April 18, 2024–(BUSINESS WIRE)–Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading global developer of industrial laser systems for cleaning and other material processing applications, announced today that it is attending the 2024 Government Fleet Expo & Conference (GFX), the largest annual conference for public fleets in the nation. Set to take place from May 7 to […]

Tiziana Life Sciences (Nasdaq: TLSA) Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology

Oral presentation of study shows intranasal foralumab attenuates microglial activation and disease progression in multiple sclerosis (MS) patients with PIRA as measured by changes in PET scans NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes […]

Mawson Infrastructure Group Inc. (NASDAQ:MIGI) Announces Monthly Operational Update for March 2024

Total Revenue Doubled with 100% Y/Y Growth from March of last year March Self-Mining Business Revenue up 182% Y/Y March Co-Location Business Revenue up 54% Y/Y March Total Revenue of about $5.44 million MIDLAND, Pa., April 18, 2024 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure company, announced […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.